Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Burdick is a venerable brand in the diagnostic cardiology sector, recognized for its long history of producing electrocardiograph (ECG) equipment and cardiac monitoring solutions. Founded in 1913, the company established itself as a leader in the primary care diagnostic market, providing essential tools for heart health assessment. Its product portfolio, which includes the well-known Atria and Quest series, is designed to provide accurate cardiac data to clinicians for the diagnosis of arrhythmias and other cardiovascular disorders. After being acquired by several entities including Quinton Cardiology, Cardiac Science, and Mortara Instrument, the Burdick brand was integrated into Hillrom and subsequently Baxter International. Today, Burdick products remain a significant part of Baxter's diagnostic cardiology portfolio, serving healthcare facilities worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Burdick.